Related Experiment Video
Updated: Mar 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[LDL-cholesterol and cardiovascular events: the lower the better?]
Raimund Weitgasser1,2, Michaela Ratzinger3, Margit Hemetsberger4
1Abteilung für Innere Medizin/Kompetenzzentrum Diabetes, Privatklinik Wehrle-Diakonissen Salzburg, Salzburg, Österreich. Raimund.Weitgasser@pkwd.at.
Decades of research confirm that lowering low-density lipoprotein (LDL) cholesterol reduces cardiovascular disease risk. Ongoing trials are expected to further solidify this causal link, enabling personalized dyslipidemia treatments.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Pharmacology
Background:
- Extensive research over 30 years has focused on low-density lipoprotein (LDL) cholesterol's role in cardiovascular disease (CVD) pathogenesis.
- Large-scale statin trials have consistently demonstrated an association between LDL cholesterol levels and cardiovascular event rates, known as the 'LDL cholesterol hypothesis'.
Purpose of the Study:
- To review the evidence supporting the causal relationship between LDL cholesterol levels and cardiovascular outcomes.
- To discuss the implications of this relationship for the individualized treatment of dyslipidemias.
Main Methods:
- Review of findings from major statin trials and recent studies on novel lipid-lowering agents.
- Analysis of the established association and proposed causal relationship between LDL cholesterol and cardiovascular events.
Main Results:
- Multiple trials confirm a strong association between LDL cholesterol and cardiovascular event rates.
- Recent studies using diverse therapeutic agents reinforce this association, indicating a causal relationship between reduced LDL cholesterol and improved cardiovascular outcomes.
Conclusions:
- The 'LDL cholesterol principle' is supported by extensive clinical trial data.
- Ongoing research is anticipated to further validate this causal link, paving the way for individualized dyslipidemia management strategies.
More Related Videos
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipids: Dietary Sources and Requirements
Coronary Artery Disease IV: Preventive Measures